LGALS9B and neoplasm: We acknowledge in this small study that there were no statistically significant differences in GAL‐9+ between patients who relapsed or remained disease‐free; though it was of interest that we found consistent absence of GAL‐9+ (GAL‐9B) tumor cells in the breast or involved nodes of relapsed patients, while GAL‐9+ tumor cells were seen in the controls.